Sun Life Financial INC lifted its position in shares of Stryker Co. (NYSE:SYK) by 455.7% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,408 shares of the medical technology company’s stock after purchasing an additional 6,075 shares during the period. Sun Life Financial INC’s holdings in Stryker were worth $1,251,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. River Wealth Advisors LLC lifted its holdings in Stryker by 1.1% in the first quarter. River Wealth Advisors LLC now owns 29,300 shares of the medical technology company’s stock worth $4,715,000 after buying an additional 309 shares during the period. Benedict Financial Advisors Inc. lifted its holdings in Stryker by 7.2% in the second quarter. Benedict Financial Advisors Inc. now owns 4,681 shares of the medical technology company’s stock worth $790,000 after buying an additional 313 shares during the period. Janney Montgomery Scott LLC lifted its holdings in Stryker by 1.5% in the second quarter. Janney Montgomery Scott LLC now owns 21,307 shares of the medical technology company’s stock worth $3,598,000 after buying an additional 316 shares during the period. Mogy Joel R Investment Counsel Inc. lifted its holdings in Stryker by 0.4% in the first quarter. Mogy Joel R Investment Counsel Inc. now owns 86,568 shares of the medical technology company’s stock worth $13,931,000 after buying an additional 325 shares during the period. Finally, Associated Banc Corp lifted its holdings in Stryker by 12.2% in the second quarter. Associated Banc Corp now owns 2,994 shares of the medical technology company’s stock worth $506,000 after buying an additional 325 shares during the period. Institutional investors own 75.08% of the company’s stock.

SYK has been the subject of several research analyst reports. Zacks Investment Research upgraded shares of Stryker from a “hold” rating to a “buy” rating and set a $192.00 price objective for the company in a report on Monday, May 21st. Royal Bank of Canada restated a “buy” rating and issued a $184.00 price objective on shares of Stryker in a report on Wednesday, July 25th. ValuEngine upgraded shares of Stryker from a “hold” rating to a “buy” rating in a report on Tuesday, June 26th. Canaccord Genuity reiterated a “buy” rating and set a $185.00 target price on shares of Stryker in a report on Wednesday, July 25th. Finally, BTIG Research initiated coverage on shares of Stryker in a report on Thursday, August 16th. They set a “buy” rating and a $187.00 target price for the company. One research analyst has rated the stock with a sell rating, eight have given a hold rating and fifteen have given a buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $178.33.

Shares of SYK stock traded down $2.57 during trading hours on Friday, hitting $170.50. 1,339,535 shares of the company’s stock traded hands, compared to its average volume of 936,250. The firm has a market capitalization of $64.81 billion, a price-to-earnings ratio of 26.27, a PEG ratio of 2.43 and a beta of 0.59. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.15 and a current ratio of 1.83. Stryker Co. has a 12-month low of $138.94 and a 12-month high of $179.84.

Stryker (NYSE:SYK) last announced its quarterly earnings results on Tuesday, July 24th. The medical technology company reported $1.76 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.73 by $0.03. The company had revenue of $3.32 billion during the quarter, compared to the consensus estimate of $3.31 billion. Stryker had a net margin of 8.28% and a return on equity of 26.93%. The firm’s quarterly revenue was up 10.3% compared to the same quarter last year. During the same quarter last year, the firm earned $1.53 earnings per share. sell-side analysts forecast that Stryker Co. will post 7.25 earnings per share for the current fiscal year.

In related news, VP Katherine Ann Owen sold 37,866 shares of the firm’s stock in a transaction that occurred on Wednesday, September 5th. The shares were sold at an average price of $166.84, for a total transaction of $6,317,563.44. Following the completion of the sale, the vice president now owns 11,367 shares of the company’s stock, valued at $1,896,470.28. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 7.40% of the stock is owned by company insiders.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties.

Featured Story: Short Selling Stocks, A Beginner’s Guide

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.